Substantial controversy exists about the prognostic role of tumor subtypes in male breast
cancer (MaBC). The aim of this study was to analyze the characteristics of each tumor …

Background Due to its rarity, few studies have characterized the epidemiology of male
breast cancer. The purpose of this study was to determine survival and risk factors for male …

Context.—The rate of male breast cancer is a small fraction of that observed in females, thus
severely limiting our understanding of the pathogenesis of this condition. It remains unclear …

Purpose: Breast cancer affects both genders, but is understudied in men. Although still rare,
male breast cancer (MBC) is being diagnosed more frequently. Treatments are wholly …

Male breast cancer is a rare disease that is still poorly understood. It is mainly classified by
immunohistochemistry as a luminal disease. In this study, we assess for the first time the …

To investigate the clinicopathological characteristics and survival outcomes of breast cancer
in the male population, 8,607 cases of patients were identified in the Surveillance …

Objective To comprehensively describe the tumor and clinical characteristics of breast
cancer in a cohort of male patients and to assess the factors that affect survival. Background …

Background The etiology of male breast cancer (MBC) is poorly understood. In particular,
the extent to which the genetic basis of MBC differs from female breast cancer (FBC) is …

Background To describe relevant pathological parameters of Danish male breast cancer
patients (MBCP) diagnosed from 1980 to 2009, and to relate these data to treatment, overall …

Biomarkers can be used for diagnosis, prognosis, and prediction in targeted therapy. The
estrogen receptor α (ERα) and human epidermal growth factor receptor 2 (HER2) are …